Raia Drogasil SA Financials

Market Capitalization R$40.48 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	35.76
Forward PE	25.65
Price to Sales TTM	R$1.07
Price to Book MRQ	R$6.42
Enterprise to Revenue	1.26
Enterprise to EBITDA	15.65

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	2.95%
Operating Margin	6.14%
Return on Assets TTM	7.12%
Return on Equity TTM	18.81%

Income Statement

Revenue TTM	R$37,701,156,864
Revenue per Share TTM	R$22.63
Quarterly Revenue Growth	15.10%
Gross Profit TTM	R$10,207,364,000
EBITDA	R$3,553,335,000
Net Income to Common TTM	R$1,110,302,976
Diluted EPS TTM	R$0.66
Quarterly Earnings Growth YoY	27.10%

Balance Sheet

Total Cash MRQ	R$410,511,008
Total Cash per Share MRQ	R$0.24
Total Debt MRQ	R$
Total Debt to Equity MRQ	119.84
Current Ratio MRQ	1.39
Book Value per Share MRQ	R$3.68

Cash Flow

Operating Cash Flow TTM	R$2,359,557,120
Levered Free Cash Flow TTM	R$1,221,106,304

RADL3 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	1,715,219,968
Float Shares	832,076,378
Avg 10 Volume	8,541,710
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	25.29%
% Held by Institutions	54.60%

Stock Price Summary

Beta	0.31
Fifty Two Week Low	R$20.20
Fifty Two Week High	R$30.40
Fifty Two Week Change	-26.56%
Day 50 MA	R$24.95
Day 200 MA	R$26.18

Dividends and Splits

Forward Annual Dividend Rate	R$0.29
Forward Annual Dividend Yield	1.39%
Trailing Annual Dividend Rate	R$0.29
Trailing Annual Dividend Yield	1.42%
Payout Ratio	47.57%
Dividend Date
Ex Dividend Date	2024-12-05
Last Split Factor
Last Split Date	2023-05-22